Evidence map›Paper›PMID 42427611›Full record

ArticlebioRxiv : the preprint server for biology2026

Distillation enables scalable high-fidelity virtual screening across ultra-large chemical libraries.

Jiawei Dai, Yueyue Wang, Naing Lin Shan, Marco Mariani, Zimeng Yu, Qin Yan, Lalit K Golani, Yulia V Surovtseva, William H Lee, Lajos Pusztai

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jiawei DaiYale Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0003-3806-5160
Yueyue WangYale Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA.
Naing Lin ShanYale Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA.
Marco MarianiYale Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA.
Zimeng YuYale Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA.
Qin YanYale Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0003-4077-453X
Lalit K GolaniYale Center for Molecular Discovery, West Haven, Connecticut, USA.
Yulia V SurovtsevaYale Center for Molecular Discovery, West Haven, Connecticut, USA.
William H LeeYale Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0003-3616-5387
Lajos PusztaiYale Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0001-9632-6686

Funding

Yale Pathology Tissue Services Shared ResourceP30CA016359 · NCI · YALE UNIVERSITY · PI Eric P. Winer · 1985 to 2026
$85.0M
Echo Acoustic Liquid Handler to Support Biomedical Research and DiscoveryS10OD038347 · OD · YALE UNIVERSITY · PI SUROVTSEVA, YULIA · 2025 to 2025
$375k
NCI NIH HHS P30 CA016359NIH HHS S10 OD038347
6 · The paper itself

Abstract

Accurate virtual screening of ultra-large chemical libraries remains challenging. Existing approaches rely on lower-fidelity scoring functions or sampling-based strategies that can limit predictive accuracy and bias the exploration of chemical space. Here, we present FastBindRank, a distillation-based framework that transfers the predictive power of the structure-based model Boltz-2 into an efficient sequence-based surrogate. Trained on ~1% of the 122-million-compound PubChem library, FastBindRank enables high-fidelity screening at scale. Applied to histone deacetylase 11 (HDAC11), FastBindRank substantially enriched high-confidence binders relative to the background chemical space. The lightweight model captured structural patterns associated with predicted binding, revealing structural determinants of binding. Under a comparable computational budget, FastBindRank achieved a 74-fold increase in hit rate and over a 30-fold increase in discovery yield over direct subset-based screening. Experimental validation confirmed the activity of two novel compounds. These results establish distillation as a practical strategy for scalable, high-fidelity virtual screening of ultra-large chemical libraries.

Identifiers

PMID42427611
PMCPMC13345133

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.